BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9518221)

  • 1. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings.
    Menor F; Marti-Bonmati L; Arana E; Poyatos C; Cortina H
    Eur J Radiol; 1998 Jan; 26(2):121-31. PubMed ID: 9518221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of white matter lesions in neurofibromatosis type 1: MR findings.
    Sevick RJ; Barkovich AJ; Edwards MS; Koch T; Berg B; Lempert T
    AJR Am J Roentgenol; 1992 Jul; 159(1):171-5. PubMed ID: 1609692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging considerations of central nervous system manifestations in pediatric patients with neurofibromatosis type 1.
    Menor F; Martí-Bonmatí L; Mulas F; Cortina H; Olagüe R
    Pediatr Radiol; 1991; 21(6):389-94. PubMed ID: 1749666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated imaging in peripheral nerve lesions in type 1 neurofibromatosis.
    Iannicelli E; Rossi G; Almberger M; Drudi FM; Giustini S; Calvieri S; David V
    Radiol Med; 2002 Apr; 103(4):332-43. PubMed ID: 12107383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential?
    Griffiths PD; Blaser S; Mukonoweshuro W; Armstrong D; Milo-Mason G; Cheung S
    Pediatrics; 1999 Oct; 104(4):e49. PubMed ID: 10506274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of brainstem gliomas in patients with neurofibromatosis 1.
    Pollack IF; Shultz B; Mulvihill JJ
    Neurology; 1996 Jun; 46(6):1652-60. PubMed ID: 8649565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.
    Terada H; Barkovich AJ; Edwards MS; Ciricillo SM
    AJNR Am J Neuroradiol; 1996 Apr; 17(4):755-60. PubMed ID: 8730197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.
    Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG
    Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities.
    Itoh T; Magnaldi S; White RM; Denckla MB; Hofman K; Naidu S; Bryan RN
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1513-9. PubMed ID: 7985572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y;
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain?
    Rüegger AD; Coleman L; Hansford JR; McLean N; Dabscheck G
    Pediatr Neurol; 2018 Sep; 86():63-65. PubMed ID: 30174245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI findings in children with neurofibromatosis type 1: a prospective study.
    Van Es S; North KN; McHugh K; De Silva M
    Pediatr Radiol; 1996 Jul; 26(7):478-87. PubMed ID: 8662066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis type 1: magnetic resonance imaging findings.
    DiMario FJ; Ramsby G; Greenstein R; Langshur S; Dunham B
    J Child Neurol; 1993 Jan; 8(1):32-9. PubMed ID: 8445170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new sign of neurofibromatosis on magnetic resonance imaging of children.
    Goldstein SM; Curless RG; Donovan Post MJ; Quencer RM
    Arch Neurol; 1989 Nov; 46(11):1222-4. PubMed ID: 2510704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
    Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment.
    Ferner RE; Chaudhuri R; Bingham J; Cox T; Hughes RA
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):492-5. PubMed ID: 8505641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.